Moffitt logo

COVID-19 Safety Precautions: Find the Latest Visitor and Mask Policies. Learn More

Articles related to Clinical Trials

Mistys Story TIL Therapy

Cervical Cancer Patient Grateful for Immunotherapy Clinical Trial

Misty, who had a rare type of cervical cancer, found hope after enrolling in a clinical trial involving tumor-infiltrating lymphocyte (TIL) therapy. Read More


Gastric Cancer

[VIDEO] Updates in Advanced Gastric Cancer

The field of gastric cancer is progressing at a rapid pace, and immuno-oncology is taking precedence with several novel combinations under investigation. Read More


Melanoma Skin Cells

[VIDEO] Nivolumab Combination Therapy May Increase Efficacy in Metastatic Melanoma Treatment

Response rates to nivolumab by itself are approximately 40%. The hope, according to Khushalani, is that the combination will offer more efficacy with less toxicity. Read More


TVEC

Moffitt Oncologists Add Oncolytic Virus to Neoadjuvant Chemo to Treat Triple-Negative Breast Cancer

Researchers are working to determine if injecting the virus directly into the tumor during chemotherapy and before surgery can help to eliminate triple negative breast cancer tumors. Read More


New Study Highlights CAR T-cell Therapy Success for Lymphoma When Used as Standard of Care

Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data Read More


Immune-Activating Drug Combination is Safe and Effective in Melanoma Patients with Brain Metastases

Ipilimumab plus nivolumab results in quick, durable responses and a manageable safety profile in patients with metastatic melanoma in the brain Read More